Is Fish oil becoming a high priced drug?
Fish oil has been known to reduce the risk of stroke and heart attacks since it is rich in Omega 3. Alternative providers have recommended Omega 3’s for heart health, cardiovascular health since it can help fight inflammation and for your overall health. The quality can vary according to the brand however, using a high quality Omega 3 supplement has been known to improve health.This is a concern for many high risk Americans, as well as for many of the Cardiologists who treat and mange them.
According to the NY Times, A large clinical trial found that the drug, called Vascepa, sharply reduced the rate of cardiovascular events in people with a history of heart disease or Type 2 diabetes, according to early results that were announced on Monday.
While this is great news for those at risk, since a drug like this being approved may be a more natural and less side effect leaden way to improve health. The concern would be cost? If they price this drug high, compared to Omega 3’s that are found in your local vitamin shop, will insurance companies pay for it as a higher priced prescription drug?
You can read more about this new medication below
Fish Oil Drug May Prevent Heart Attack and Strokes in High-Risk Patients
Large doses of an omega-3 fatty acid in fish oil sharply reduced the rate of cardiovascular events in people with a history of heart disease or Type 2 diabetes.
By Anahad O’Connor Sept. 25, 2018
Cardiologists may one day have a new tool to help prevent heart attacks and strokes in some high-risk patients: a prescription drug that contains large doses of EPA, an omega-3 fatty acid contained in fish oil.
A large clinical trial found that the drug, called Vascepa, sharply reduced the rate of cardiovascular events in people with a history of heart disease or Type 2 diabetes, according to early results that were announced on Monday.
The findings were particularly relevant for people with high triglycerides, a type of fat in the blood that has been linked to an increased risk of heart disease. The new trial, called Reduce-IT, focused on people whose cholesterol levels were well controlled with statins but whose triglyceride levels remained very high. Many cardiovascular experts were doubtful that adding fish oil on top of statins would produce much if any benefit because a number of smaller and less rigorous studies over the years had failed.